Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Most parathyroid adenomas and some pathological parathyroid glands from patients with primary parathyroid hyperplasia or severe uremic secondary/tertiary hyperparathyroidism show an elevated set-point [the extracellular Ca2+ concentration (Ca2+o) half-maximally inhibiting PTH secretion]. In the present study, we investigated whether expression of the Ca2+o-sensing receptor protein recently cloned from bovine parathyroid, a key component in Ca2+o-regulated PTH release, is altered in primary and uremic hyperparathyroidism. Using immunohistochemistry with specific antireceptor antibodies, we compared immunoreactivity of the receptor protein in 14 adenomas, biopsies of 24 normal glands from this same group of patients, and 8 hyperplastic parathyroid glands from 2 individuals with uremic hyperparathyroidism. The results show a substantial reduction in the intensity of immunostaining for the receptor protein that averaged nearly 60% for both adenomas and hyperplastic glands, as quantitated by image analysis. Although normal glands from normocalcemic controls were not available, the intensity of receptor staining in normal glands from patients with adenomas was comparable to that in normal bovine, rat, and mouse parathyroid glands. There was considerable variation in staining intensity among different pathological parathyroid glands, even in those from the same patient with secondary hyperparathyroidism. In addition, both adenomas and hyperplastic glands had, in some cases, isolated chief cells and groups of cells, sometimes around the periphery of an abnormal gland, with receptor staining equivalent to that of normal parathyroid cells, whereas the bulk of the cells in the same gland showed a marked decrease in staining. Thus, there is a variable, but substantial, reduction in the immunoreactivity of the Ca2+o-sensing receptor protein in both parathyroid adenomas and uremic hyperparathyroidism, as assessed by immunohistochemistry, that probably results from reduced expression of the receptor protein and may contribute to the increase in the set-point often observed in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Khosla, S. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.3.715 · Cited by 177
Cited by
Extracellular Calcium Sensing and Extracellular Calcium Signaling
Brown, E. M., & MacLeod, R. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.239 · Cited by 1,388
Gogusev, J., Duchambon, P., Hory, B., Giovannini, M., Goureau, Y., Sarfati, E., & Drüeke, T. B. (1997) · Kidney International · doi:10.1038/ki.1997.41 · Cited by 493
Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder
Fukagawa, M., Yokoyama, K., Koiwa, F., Taniguchi, M., Shoji, T., Kazama, J. J., Komaba, H., Ando, R., Kakuta, T., Fujii, H., et al. (2013) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12058 · Cited by 402
Human Calcium-sensing Receptor Gene
Canaff, L., & Hendy, G. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201804200 · Cited by 402
The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases
Hannan, F. M., Kallay, E., Chang, W., Brandi, M. L., & Thakker, R. V. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0115-0 · Cited by 394
Pathogenesis of secondary hyperparathyroidism
Slatopolsky, E., Brown, A., & Dusso, A. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.07304.x · Cited by 309
Hormones and Disorders of Mineral Metabolism
Bringhurst, F. R., Demay, M. B., & Kronenberg, H. M. (2011) · Williams Textbook of Endocrinology · doi:10.1016/b978-1-4377-0324-5.00028-6 · Cited by 298
THE CALCIUM-SENSING RECEPTOR IN NORMAL PHYSIOLOGY AND PATHOPHYSIOLOGY: A Review
Tfelt-Hansen, J., & Brown, E. M. (2005) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360590886606 · Cited by 289
Metabolic Bone Disease in Chronic Kidney Disease
Martin, K. J., & González, E. A. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070771 · Cited by 288
Hendy, G. N., D'Souza-Li, L., Yang, B., Canaff, L., & Cole, D. E. C. (2000) · Human Mutation · doi:10.1002/1098-1004(200010)16:4<281::aid-humu1>3.0.co;2-a · Cited by 277
Kifor, O., MacLeod, R. J., Diaz, R., Bai, M., Yamaguchi, T., Yao, T., Kifor, I., & Brown, E. M. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.2.f291 · Cited by 273
Self-citationKomaba, H., Goto, S., Fujii, H., Hamada, Y., Kobayashi, A., Shibuya, K., Tominaga, Y., Otsuki, N., Nibu, K.-I., Nakagawa, K., et al. (2010) · Kidney International · doi:10.1038/ki.2009.414 · Cited by 267
Wada, M., Furuya, Y., Sakiyama, J., Kobayashi, N., Miyata, S., Ishii, H., & Nagano, N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119851 · Cited by 255
Metadata
- Authors
- Kifor, O.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1996-04-01
- Volume
- 81
- Issue
- 4
- Pages
- 1598-1606
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W1994494042
- Cited by
- 500
- References
- 1
- FWCI
- 30.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.